Evidence map›Paper›PMID 15208661›Full record

ArticleOncogene2004

Role of IFI 16 in cellular senescence of human fibroblasts.

Hong Xin, Olivia M Pereira-Smith, Divaker Choubey

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium.Mammalian genome : official journal of the International Mammalian Genome Society · 2015
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Differential network analysis in human cancer research.Current pharmaceutical design · 2014
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hong XinDepartment of Radiation Oncology, Stritch School of Medicine, Loyola University Medical Center, 2160 South First Avenue, Mail code 114B, Maywood, IL 60153, USA.
Olivia M Pereira-Smith
Divaker Choubey
Loyola University Medical Center · USThe University of Texas Health Science Center at San Antonio · US

Funding

STUDIES OF THE MRG15 GENE IN CELL CYCLE AND CELL SENESCENCEP01AG020752 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI SMITH, JAMES · 2001 to 2005
$8.5M
Role of IFI 16 in Cellular Senescence and AgingR03AG022124 · NIA · LOYOLA UNIVERSITY CHICAGO · PI CHOUBEY, DIVAKER · 2003 to 2003
$74k
NIA NIH HHS AG022124NIA NIH HHS P01 AG20752
6 · The paper itself

Abstract

Defects in interferon (IFN) signaling that result in loss of expression of IFN-inducible proteins are associated with cellular immortalization, an important early event in the development of human cancer. Here we report that loss of IFN-inducible IFI 16 expression in human fibroblasts allows bypass of cellular senescence. We found that levels of IFI 16 mRNA and protein were higher in human old versus young fibroblasts and immortalization of fibroblasts with telomerase resulted in decreased expression of IFI 16. Moreover, overexpression of IFI 16 in immortalized fibroblasts strongly inhibited cell proliferation. Interestingly, knockdown of IFI 16 expression in fibroblasts inhibited p53-mediated transcription, downregulated p21(WAF1) expression, and extended the proliferation potential. Importantly, treatment of immortal cell lines with 5-aza-2'-deoxycytidine, an inhibitor of DNA methyltransferase, resulted in upregulation of IFI 16. Our observations support the idea that increased levels of IFI 16 in older populations of human fibroblasts contribute to cellular senescence.

Indexed as

Cell Line, TransformedCellular SenescenceCyclin-Dependent Kinase Inhibitor p21CyclinsFibroblastsHumansNuclear ProteinsPhosphoproteinsTranscription, GeneticTumor Suppressor Protein p53CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21CyclinsIFI16 protein, humanNuclear ProteinsPhosphoproteinsTumor Suppressor Protein p53

Identifiers

PMID15208661
OpenAlexW2065870221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.